INTERFERONS: ANTINEOPLASTIC DRUGS.STRANDER H.1977; BLUT; DTSCH.; DA. 1977; VOL. 35; NO 4; PP. 277-288; BIBL. 6 P.Article

Interferon treatment of human neoplasiaSTRANDER, H.Advances in cancer research. 1986, Vol 46, issn 0065-230X, X-265 pSerial Issue

INTERFERON IN CANCER: FAITH, HOPE, AND REALITYSTRANDER H; EINHORN S.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 3; PP. 297-301; BIBL. 32 REF.Article

INTERFERON THERAPY IN NEOPLASTIC DISEASES = TRAITEMENT PAR L'INTERFERON DES MALADIES NEOPLASIQUESSTRANDER H; EINHORN S.1982; PHILOS. TRANS. R. SOC. LOND., SER. B; ISSN 0080-4622; GBR; DA. 1982; VOL. 299; NO 1094; PP. 113-117; BIBL. 19 REF.Article

EFFECT OF HUMAN LEUKOCYTE INTERFERON ON THE GROWTH OF HUMAN OSTEOSARCOMA CELLS IN TISSUE CULTURE.STRANDER H; EINHORN S.1977; INTERNATION. J. CANCER; SWITZ.; DA. 1977; VOL. 19; NO 4; PP. 468-473; ABS. FR.; BIBL. 16 REF.Article

TRAITEMENT DE L'OSTEOSARCOME PAR L'INTERFERON ET LA CHIRURGIE DIFFERENCIEENILSONNE U; STRANDER H.1981; REV. CHIR. ORTHOP. REPAR. APPAR. MOT.; ISSN 0035-1040; FRA; DA. 1981; VOL. 67; NO 3; PP. 193-197; ABS. ENG; BIBL. 14 REF.Article

IS INTERFERON TISSUE SPECIFIC. EFFECT OF HUMAN LEUKOCYTE AND FIBROBLAST INTERFERONS ON THE GROWTH OF LYMPHOBLASTOID AND OSTEOSARCOMA CELL LINES.EINHORN S; STRANDER H.1977; J. GEN. VIROL.; G.B.; DA. 1977; VOL. 35; NO 3; PP. 573-577; BIBL. 15 REF.Article

SURVIVAL IN OSTEOSARCOMA IN RELATION TO TUMOR SIZE AND LOCATIONBROSTROEM LA; STRANDER H; NILSONNE U et al.1982; CLIN. ORTHOP. RELAT. RES.; ISSN 0009-921X; USA; DA. 1982; NO 167; PP. 250-254; BIBL. 24 REF.Article

CORRELATION BETWEEN PROGNOSTIC FACTORS AND BLOOD VARIABLES IN OSTEOSARCOMABROSTROEM LA; INGIMARSSON S; STRANDER H et al.1980; ACTA MED. SCAND.; SWE; DA. 1980; VOL. 207; NO 5; PP. 429-431; BIBL. 15 REF.Article

INTERFERON AND SPONTANEOUS CYTOTOXICITY IN MAN. V: ENHANCEMENT OF SPONTANEOUS CYTOTOXICITY IN PATIENTS RECEIVING HUMAN LEUKOCYTE INTERFERONEINHORN S; BLOMGREN H; STRANDER H et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 4; PP. 419-428; BIBL. 25 REF.Article

INTERFERON AND SPONTANEOUS CYTOTOXICITY IN MAN. II: STUDIES IN PATIENTS RECEIVING EXOGENOUS LEUKOCYTE INTERFERONEINHORN S; BLOMGREN H; STRANDER H et al.1978; ACTA MED. SCAND.; SWE; DA. 1978; VOL. 204; NO 6; PP. 477-483; BIBL. 25 REF.Article

VIRUS INFECTIONS AND RECURRENCE OF OSTEOSARCOMA IN PATIENTS RECEIVING HUMAN LEUKOCYTE INTERFERONINGIMARSSON S; CANTELL K; STRANDER H et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 4; PP. 395-399; BIBL. 31 REF.Article

SENSITIVITY OF THE EPSTEIN-BARR VIRUS TRANSFORMED HUMAN LYMPHOID CELL LINES TO INTERFERONADAMS A; STRANDER H; CANTELL K et al.1975; J. GEN. VIROL.; G.B.; DA. 1975; VOL. 28; NO 2; PP. 207-217; BIBL. 1 P. 1/2Article

Clinical effects of interferon therapy with special emphasis on antitumor efficacySTRANDER, H. A.Acta oncologica (Stockholm). 1989, Vol 28, Num 3, pp 355-362, issn 0284-186X, 8 p.Conference Paper

EFFECT OF AN INTRAMUSCULAR INJECTION OF HUMAN LEUKOCYTE INTERFERON ON BLOOD LEUKOCYTE COUNTS AND PROPORTIONS OF LYMPHOCYTES FORMING E, EA AND EAC ROSETTESEINHORN S; BLOMGREN H; STRANDER H et al.1980; INT. ARCH. ALLERGY APPL. IMMUNOL.; ISSN 0020-5915; CHE; DA. 1980; VOL. 63; NO 2; PP. 139-144; BIBL. 18 REF.Article

SIDE EFFECTS OF LONG-TERM TREATMENT WITH HUMAN LEUKOCYTE INTERFERONINGIMARSSON S; CANTELL K; STRANDER H et al.1979; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1979; VOL. 140; NO 4; PP. 560-563; BIBL. 15 REF.Article

INTERFERON AND SPONTANEOUS CYTOTOXICITY IN MAN. I. ENHANCEMENT OF THE SPONTANEOUS CYTOTOXICITY OF PERIPHERAL LYMPHOCYTES BY HUMAN LEUKOCYTE INTERFERONEINHORN S; BLOMGREN H; STRANDER H et al.1978; INTERNATION. J. CANCER; CHE; DA. 1978; VOL. 22; NO 4; PP. 405-412; ABS. FRE; BIBL. 42 REF.Article

EFFECT OF HUMAN LEUKOCYTE INTERFERON ON THE RESPONSE OF LYMPHOCYTES TO MITOGENIC STIMULI IN VITROBLOMGREN H; STRANDER H; CANTELL K et al.1974; SCAND. J. IMMUNOL.; NORWAY; DA. 1974; VOL. 3; NO 6; PP. 697-705; BIBL. 1 P.Article

ADJUVANT INTERFERON TREATMENT AND THE LATE DEVELOPMENT OF CEREBREAL METASTASES IN A PATIENT WITH OSTEOSARCOMABROSTROEM LA; INGIMARSON S; STRANDER H et al.1980; ACTA ORTHOP. SCAND.; DNK; DA. 1980; VOL. 51; NO 4; PP. 589-594; BIBL. 14 REF.Article

EFFECT OF LONG-TERM TREATMENT WITH HUMAN LEUKOCYTE INTERFERON ON VARIOUS LABORATORY PARAMETERSINGIMARSSON S; BERGSTROEM K; BROSTROEM LA et al.1980; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1980; VOL. 208; NO 3; PP. 155-159; BIBL. 14 REF.Article

IN VITRO AND IN VIVO EFFECTS OF INTERFERON ON THE RESPONSE OF HUMAN LYMPHOCYTES TO MITOGENSEINHORN S; BLOMGREN H; EINHORN N et al.1983; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1983; VOL. 51; NO 2; PP. 369-374; BIBL. 13 REF.Article

INTERFERON THERAPY IN JUVENILE LARYNGEAL PAPILLOMATOSISHAGLUND S; LUNDQUIST PG; CANTELL K et al.1981; ARCH. OTOLARYNGOL. (1960); ISSN 0003-9977; USA; DA. 1981; VOL. 107; NO 6; PP. 327-332; BIBL. 25 REF.Article

Studies with interferon α in human tumorsEINHORN, S; STRANDER, H.Medical oncology and tumor pharmacotherapy. 1984, Vol 1, Num 2, pp 97-99, issn 0736-0118Article

HUMAN LEUKOCYTE INTERFERON THERAPY FOR ADVANCED OVARIAN CARCINOMAEINHORN N; CANTELL K; EINHORN S et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 2; PP. 167-172; BIBL. 13 REF.Article

SPONTANEOUS INTERFERON PRODUCTION AND EPSTEIN-BARR VIRUS ANTIGEN EXPRESSION IN HUMAN LYMPHOID CELL LINESADAMS A; LIDIN B; STRANDER H et al.1975; J. GEN. VIROL.; G.B.; DA. 1975; VOL. 28; NO 2; PP. 219-223; BIBL. 10 REF.Article